The Leukemia and Lymphoma Society (LLS) and WealthEngine (WE), the top supplier of predictive analytics, marketing and audience development services, recently partnered to raise funds for blood cancer research.
LLS is the world’s biggest voluntary health agency focused on fighting blood cancer. Joined with WE, the two organizations seek to transform the world into a place where blood cancer does not exist. To accomplish this, they will heighten overall donor development strategies using data, solutions and analytics that are applicable to health campaigns.
"We are extremely proud to work with The Leukemia and Lymphoma Society and welcome them to the WealthEngine family," Mark Logan, president and CEO of WealthEngine, said. "At WealthEngine, we look to empower nonprofits and provide them with solutions to fulfill their missions, and that's what we're doing with LLS. We look forward to a long and successful relationship with them."
In turn, WE will offer comprehensive wealth insights so that LLS can have profiles of prospective as well as current donors in their Salesforce database.
"We are very excited to join with WealthEngine: they have a passion and dedication for helping nonprofits reach their fundraising goals to further their missions," Claude Edkins, senior vice president and chief information officer at LLS, said. "Using WealthEngine along with Salesforce will help us become much more data-driven and drive fundraising results. As a result, we have already increased our major gift thresholds."
